- Conditions
- Anemia, Anemia, Aplastic, Anemia, Diamond-Blackfan, +32 more
- Locations
-
- UCSF Comprehensive Cancer Center San Francisco, California, United States
Clinical trial condition
Leukemia
Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.
1,218 public trials
94 recruiting studies
Leukemia trial results
NCT00295971
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +21 more
- Locations
-
- UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
Completed
Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant
NCT00900406
- Conditions
- Adnexal Diseases, Blood Protein Disorders, Bone Marrow Diseases, +58 more
- Locations
-
- Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States
- Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States
- Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
NCT00005622
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +56 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
NCT00255749
- Conditions
- Amyloidosis, Anemia, Blood Protein Disorders, +64 more
- Locations
-
- Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States
NCT00296023
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +64 more
- Locations
-
- Alta Bates Comprehensive Cancer Center Berkeley, California, United States
- UCSF Comprehensive Cancer Center San Francisco, California, United States
NCT00787761
- Conditions
- Adenocarcinoma, Blast Crisis, Blood Protein Disorders, +82 more
- Locations
-
- Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
Completed
A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide
NCT00005793
- Conditions
- Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
Completed
Phase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar CPT-11)
NCT00005626
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +20 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
NCT00003805
- Conditions
- Blast Crisis, Blood Protein Disorders, Body Temperature Changes, +69 more
- Locations
-
- Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States
- Boston Medical Center Boston, Massachusetts, United States
- Algemeen Ziekenhuis Middelheim Antwerp, Belgium
- Hopital Universitaire Erasme Brussels, Belgium